<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>S3422</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.fronterpagebillhead
	{mso-style-name:fronterpagebillhead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FPHangingAnAct, li.FPHangingAnAct, div.FPHangingAnAct
	{mso-style-name:FPHangingAnAct;
	mso-style-link:"FPHangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.4in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.FPHangingAnActChar
	{mso-style-name:"FPHangingAnAct Char";
	mso-style-link:FPHangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>SENATE, No. 3422 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED JUNE 10, 2024</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  RENEE C. BURGESS</p>

<p class=bpuSponsor>District 28 (Essex and Union)</p>

<p class=bpuSponsor>Senator  BRITNEE N. TIMBERLAKE</p>

<p class=bpuSponsor>District 34 (Essex)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>Co-Sponsored by:</p>

<p class=bpuSponsor>Senator Gopal</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Cancer Patient Care and Compassion Act. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As introduced.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> concerning certain protections for cancer patients and amending
and supplementing various parts of the statutory law.</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.    (New section)  Sections
1 through 6 of this act shall be known and may be cited as the Cancer Patient
Care and Compassion Act.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.    (New section)  a.  A
contract that provides hospital or medical expense benefits and is delivered,
issued, executed, or renewed in this State by a carrier, the State Health
Benefits Commission, or the School Employees Health Benefits Commission, or is
approved for issuance or renewal in this State by the Commissioner of Banking
and Insurance, on or after the effective date of P.L. &nbsp;&nbsp;&nbsp;, c.    (C.       
)  (pending before the Legislature as this bill), shall provide coverage for
individuals diagnosed with cancer and with a prognosis that is deemed Stage
III, Stage IV, or terminal:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   parenteral treatment of
the cancer;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   survivorship care plan,
including follow-up appointments; and    </p>

<p class=MsoNormal style='line-height:150%'>     (3)   any other service or
item, as determined by the Commissioner of Banking and Insurance.         </p>

<p class=MsoNormal style='line-height:150%'>     b.    A contract subject to
this section shall not impose a coinsurance, copayment, or any other cost-sharing
requirement on the coverage required under this section.</p>

<p class=MsoNormal style='line-height:150%'>     c.     The provisions of this
section shall apply to all contracts in which the carrier has reserved the
right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     d.    As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     Parenteral treatment means the
intravenous, intra-arterial, intraperitoneal, or intrathecal administration of
nutrition or medication bypassing the gastrointestinal system.</p>

<p class=MsoNormal style='line-height:150%'>     Survivorship care plan means
a plan for an individual with cancer from diagnosis through the end of life that
focuses on the health and well-being of the individual.  This includes, but is
not limited to, side effects from treatment, cancer recurrence, and quality of
life.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    (New section)  a.  Notwithstanding
any State law or regulation to the contrary, the Department of Human Services
shall ensure that expenses incurred for the following services shall be
provided with no cost-sharing to persons served under the Medicaid program,
established pursuant to P.L.1968, c.413 (C.30:4D-1&nbsp;et&nbsp;seq.) for
individuals diagnosed with cancer and with a prognosis that is deemed Stage
III, Stage IV, or terminal:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   parenteral treatment of
the cancer;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   survivorship care plan,
including follow-up appointments; and    </p>

<p class=MsoNormal style='line-height:150%'>     (3)   any other service or
item, as determined by the department.</p>

<p class=MsoNormal style='line-height:150%'>     b.    Any copayment or
coinsurance that may be required pursuant to the contract for services covered
pursuant to subsection a. of this section shall not apply.</p>

<p class=MsoNormal style='line-height:150%'>     c.     The department may take
any administrative action necessary to effectuate the provisions of this
section.</p>

<p class=MsoNormal style='line-height:150%'>     d.    <span style='color:black'>As
used in this section:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     </span>Carrier
means an insurance company, health service corporation, hospital service
corporation, medical service corporation, or health maintenance organization
authorized to issue health benefits plans in this State.</p>

<p class=MsoNormal style='line-height:150%'>     Parenteral treatment means
the intravenous, intra-arterial, intraperitoneal, or intrathecal administration
of nutrition or medication bypassing the gastrointestinal system.</p>

<p class=MsoNormal style='line-height:150%'>     Survivorship care plan means
a plan for an individual with cancer from diagnosis through the end of life
that focuses on the health and well-being of the individual.  This includes,
but is not limited to, side effects from treatment, cancer recurrence, and
quality of life.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4.    (New section)  a. 
Before a residential mortgage lender provides a notice of intention to a
residential mortgage debtor pursuant to section 4 of P.L.1995, c.244
(C.2A:50-56), and before the residential mortgage lender accelerates the
maturity of a residential mortgage obligation and commences a foreclosure
action to take possession of the residential property that is the subject of
the mortgage, the residential mortgage lender shall ensure that a residential
mortgage debtor is not undergoing treatment for Stage III, Stage IV, or
terminal cancer.  If a residential mortgage debtor is undergoing treatment for Stage
III, Stage IV, or terminal cancer, the residential mortgage lender shall not
provide a notice of intention to the residential mortgage debtor until the
residential mortgage lender receives notice from the physician treating the
residential mortgage debtor that the debtor is no longer undergoing treatment.</p>

<p class=MsoNormal style='line-height:150%'>     b.    Any foreclosure action
to take possession of a residential property shall be dismissed upon submission
by the residential mortgage debtor to the residential mortgage lender of a
letter from the physician of the debtor certifying that the debtor is
undergoing treatment for Stage III, Stage IV, or terminal cancer.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     5.    (New section)  a.  A
creditor shall not initiate a collection proceeding for a default on any debt
against an individual who is undergoing treatment for Stage III, Stage IV, or
terminal cancer and who submits to the creditor a letter from the individuals
physician certifying treatment of the individual for Stage III, Stage IV, or terminal
cancer.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    Any collection
proceeding against an individual who is undergoing treatment for Stage III,
Stage IV, or terminal cancer shall be dismissed upon submission by the
individual to the creditor of a letter from the individuals physician
certifying treatment of the individual for Stage III, Stage IV, or terminal
cancer.</p>

<p class=MsoNormal style='line-height:150%'>     c.     As used in this
section:</p>

<p class=MsoNormal style='line-height:150%'>     Collection proceeding means
actions related to the collection of an individuals debt that require a legal
or judicial process, including, but not limited to, placing a lien on an
individual's property, attaching or seizing an individual's bank account or any
other personal property, commencing a civil action against an individual, or
garnishing an individual's wages.</p>

<p class=MsoNormal style='line-height:150%'>     Creditor means a federal or
State chartered bank, savings bank, savings and loan association or credit
union, any person required to be licensed under the provisions of the New
Jersey Consumer Finance Licensing Act, P.L.2009, c.53 (C.17:11C-51 et al.) and
any entity acting on behalf of the creditor named in the debt obligation
including, but not limited to, servicers, and any entity operating as a
collection agency or in the business of purchasing debt.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     6.    (New section)  For an
eviction action based on nonpayment or habitual late payment of rent, or
failure to pay a rent increase, the Superior Court shall authorize a stay of
eviction, for a period of time not to exceed 45 days, if the tenant is an
individual undergoing treatment for Stage III, Stage IV, or terminal
cancer.&nbsp; </p>

<p class=MsoNormal style='line-height:150%'>     a.     For a tenant to be
entitled to a stay of eviction pursuant to this section, the tenant shall
submit a certification from the treating physician, which shall be deemed
confidential and submitted under seal.&nbsp; </p>

<p class=MsoNormal style='line-height:150%'>     b.    During the time of the
stay of eviction provided pursuant to this section, the tenant shall be
entitled to renew the lease at its term of expiration, subject to reasonable
changes proposed to the tenant by the landlord.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     7.    Section 24 of P.L.2019,
c.37 (C.43:21-55.2) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     24.  a.  <u>Any covered
individual who took any temporary disability benefits pursuant to P.L.1948,
c.110 (C.43:21-25 et al.), or family temporary disability leave benefits
pursuant to P.L.2008, c.17 (C.43:21-39.1 et al.), shall, upon the expiration of
the leave, be entitled to be restored by the employer to the position held by
the employee when the leave commenced or to an equivalent position of like
seniority, status, employment benefits, pay, and other terms and conditions of
employment.  If, during that period of leave, the employer has a reduction in
force or layoffs and the employee would have lost the employees position had
the employee not been on the leave as a result of the reduction in force or
layoff, or pursuant to the good faith operation of a bona fide layoff and
recall system including a system under an applicable collective bargaining
agreement, the employee shall not be entitled to reinstatement to the former or
an equivalent position, if the employer notifies the employee of the employees
right pursuant to paragraph (2) of subsection (c) of R.S.43:21-19 to file a
claim for unemployment benefits after the leave period ends.  The employee
shall retain all rights under any applicable layoff and recall system,
including a system under a collective bargaining agreement, as if the employee
had not taken the leave.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>b.</u>    An employer shall
not discharge, harass, threaten, or otherwise discriminate or retaliate against
an employee with respect to the compensation, terms, conditions, or privileges
of employment on the basis that the employee requested or took any temporary
disability benefits pursuant to P.L.1948, c.110 (C.43:21-25 et al.), or family
temporary disability leave benefits pursuant to P.L.2008, c.17 (C.43:21-39.1 et
al.), including retaliation by refusing to <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>restore<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>reinstate
to equivalent employment</u>  the employee following a period of leave <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>, except that,
pursuant to section 2 of P.L.1948, c.110 (C.43:21-26), nothing in this section
or any other section of P.L.1948, c.110 (C.43:21-25 et al.) or P.L.2008, c.17
(C.43:21-39.1 et al.) shall be construed as increasing, reducing or otherwise
modifying any entitlement provided to a worker by the provisions of the
&quot;Family Leave Act,&quot; P.L.1989, c.261 (C.34:11B-1 et seq.) to be
restored to employment by the employer after a period of family temporary
disability leave<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
<u>as required by subsection a. of this section</u> .</p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     During any period
that temporary disability benefits are provided pursuant to P.L.1948, c.110
(C.43:21-25 et al.), or family temporary disability leave benefits provided
pursuant to P.L.2008, c.17 (C.43:21-39.1 et al.), the employer shall:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   maintain coverage
under any group health insurance policy, group subscriber contract or health
care plan at the same level and with the same or equivalent terms, including
the employees cost of coverage, such as premium contributions, co-pays, and
deductibles, as would have been provided if the employees employment had been continuous
throughout that period; and</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   provide, in addition
to the benefits required by this section, any other employment benefits that
would be provided pursuant to the employer's policy for employees on temporary
leave from employment.</u></p>

<p class=MsoNormal style='line-height:150%'>     <b><span style='font-family:
"Albertus Extra Bold",sans-serif'>[</span></b>b.<b><span style='font-family:
"Albertus Extra Bold",sans-serif'>]</span></b> <u>d.</u>  Upon a violation of
subsection a.<u>, b. or c.</u> of this section, <u>including a failure of the
employer to restore an employee to the position the employee held prior to
leave under subsection b. of this section,</u> an employee or former employee <u>affected
by the violation</u> may <u>take one of the following actions:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   file a written
complaint with the Commissioner of Labor and Workforce Development to seek
reinstatement to employment. If the employer is found by a preponderance of the
evidence to be in violation, the commissioner shall order the reinstatement the
employee to the position previously held with no reduction in seniority,
status, employment benefits, pay, and other terms and conditions of employment,
compensation for any lost wages, benefits and other remuneration, and fine the
employer $2,500 for each violation of subsection a., b. or c. of this section,
or  </u> </p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)</u>   institute a civil
action in the Superior Court for relief.  All remedies available in common law
tort actions shall be available to a prevailing plaintiff.  The court may also
order any or all of the following relief:</p>

<p class=MsoNormal style='line-height:150%'>     <b><span style='font-family:
"Albertus Extra Bold",sans-serif'>[</span></b>(1)<b><span style='font-family:
"Albertus Extra Bold",sans-serif'>]</span></b> <u>(a)</u>     an assessment of
a civil fine of not less than $1,000 and not more than $2,000 for the first
violation of any of the provisions of this section and not more than $5,000 for
each subsequent violation;</p>

<p class=MsoNormal style='line-height:150%'>     <b><span style='font-family:
"Albertus Extra Bold",sans-serif'>[</span></b>(2)<b><span style='font-family:
"Albertus Extra Bold",sans-serif'>]</span></b> <u>(b)</u>     an injunction to
restrain the continued violation of any of the provisions of this section;</p>

<p class=MsoNormal style='line-height:150%'>     <b><span style='font-family:
"Albertus Extra Bold",sans-serif'>[</span></b>(3)<b><span style='font-family:
"Albertus Extra Bold",sans-serif'>]</span></b> <u>(c)</u>     reinstatement of
the employee to the same position or to a position equivalent to that which the
employee held prior to</p>

<p class=MsoNormal style='line-height:150%'>unlawful discharge or retaliatory
action<u>, or other failure to reinstate the employee in violation of this
section</u>;</p>

<p class=MsoNormal style='line-height:150%'>     <b><span style='font-family:
"Albertus Extra Bold",sans-serif'>[</span></b>(4)<b><span style='font-family:
"Albertus Extra Bold",sans-serif'>]</span></b> <u>(d)</u>     reinstatement of
full fringe benefits and seniority rights;</p>

<p class=MsoNormal style='line-height:150%'>     <b><span style='font-family:
"Albertus Extra Bold",sans-serif'>[</span></b>(5)<b><span style='font-family:
"Albertus Extra Bold",sans-serif'>]</span></b> <u>(e)</u>     compensation for
any lost wages, benefits and other remuneration; and</p>

<p class=MsoNormal style='line-height:150%'>     <b><span style='font-family:
"Albertus Extra Bold",sans-serif'>[</span></b>(6)<b><span style='font-family:
"Albertus Extra Bold",sans-serif'>]</span></b> <u>(f)</u>     payment of
reasonable costs and attorney's fees.</p>

<p class=MsoNormal style='line-height:150%'>     <u>e.     An employee who is
eligible for both earned sick leave pursuant to P.L.2018, c.10 (C.34:11D-1 et
seq.). and either temporary disability benefits pursuant to P.L.1948, c. 110
(C.43:21-25 et al.), or family temporary disability leave benefits pursuant to
P.L.2008, c. 17 (C.43:21-39.1 et al.) shall have the option of using either the
earned sick leave or whichever is applicable of temporary disability benefits
or family temporary disability leave benefits, and may select the order in
which the different kinds of leave are taken, but shall not receive more than
one kind of paid leave simultaneously during any period of time.</u></p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2019, c.37, s.24)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     8.    This act shall take
effect on the first day of the fourth month next after enactment and shall
apply to all policies, plans, and contracts delivered, issued, executed, or
renewed on or after the effective date. </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill, to be known as the
Cancer Patient Care and Compassion Act, provides certain protections for Stage
III, Stage IV, or terminal cancer patients.  The bill:</p>

<p class=MsoNormal style='line-height:150%'>     1.    Requires health
insurance carriers (including health service corporations, hospital service
corporations, medical service corporations, commercial individual and group
health insurers, and health maintenance organizations), entities contracted to
administer health benefits in connection with the State Health Benefits Program
and School Employees Health Benefits Program, and the NJ FamilyCares/Medicaid
program to provide coverage for individuals diagnosed with cancer and with a
prognosis that is deemed Stage III, Stage IV, or terminal  (1) parenteral
treatment of the cancer; (2) survivorship care plan, including follow-up
appointments; and (3) any other service or item as determined by the regulators
of each type of carrier or contract.  Under the bill, parenteral treatment
means the intravenous, intra-arterial, intraperitoneal, or intrathecal administration
of nutrition or medication bypassing the gastrointestinal system and
survivorship care plan means a plan for an individual with cancer from
diagnosis through the end of life that focuses on the health and well-being of
the individual.  This includes, but is not limited to, side effects from
treatment, cancer recurrence, and quality of life.  Any cost-sharing or
copayment or coinsurance that may be required for coverage will not apply.</p>

<p class=MsoNormal style='line-height:150%'>     2.    Prohibits residential
mortgage lenders from providing a notice of intention to a residential mortgage
debtor undergoing treatment for Stage III, Stage IV, or terminal cancer.  Under
the bill, a residential mortgage lender shall ensure, before sending a notice
of intention to cure a default on a mortgage debtors residential mortgage
obligation, that the residential mortgage debtor is not undergoing treatment
for Stage III, Stage IV, or terminal cancer.  If a mortgage debtor is
undergoing treatment, the mortgage lender will be prohibited from providing a
notice of intention to the mortgage debtor until the mortgage lender receives
notice from the physician of the mortgage debtor that the debtor is no longer
undergoing treatment.  Additionally, the bill provides that any foreclosure
action to take possession of a residential property will be dismissed upon
submission by the residential mortgage debtor to the residential mortgage
lender of a letter from the physician of the debtor certifying that the debtor
is undergoing treatment for Stage III, Stage IV, or terminal cancer.</p>

<p class=MsoNormal style='line-height:150%'>     3.    Prohibits a creditor
from initiating a collection proceeding for a default on any debt against an
individual who is undergoing treatment for Stage III, Stage IV, or terminal
cancer and who submits to the creditor a letter from the individuals physician
certifying treatment of the individual for Stage III, Stage IV, or terminal
cancer.  The bill also provides that any collection proceeding against an individual
who is undergoing treatment for Stage III, Stage IV, or terminal cancer is
required to be dismissed upon submission by the individual of a letter from the
individuals physician certifying treatment of the individual for Stage III,
Stage IV, or terminal cancer.</p>

<p class=MsoNormal style='line-height:150%'>     4.    Requires that for
eviction actions based on nonpayment or habitual late payment of rent, or for
failure to pay a rent increase, the Superior Court will authorize a stay of
eviction for up to 45 days if the tenant is actively undergoing Stage III,
Stage IV, or terminal cancer treatment.  To qualify for this stay, the tenant
must provide a confidential certification from their treating physician,
submitted under seal. Additionally, during the stay period, the tenant has the
right to renew their lease upon its expiration, subject to reasonable changes
proposed by the landlord.</p>

<p class=MsoNormal style='line-height:150%'>     The bill also provides the
right to reinstatement to equivalent employment after a period of leave applies
to all periods in which TDI or FLI benefits are provided, including extending
that right to FLI leave takers employed by employers with less than 30
employees, as is presently the case for TDI leave takers.  Under the bill, an
employee who is eligible for both earned sick leave and either TDI or FLI
benefits, may use either the earned sick leave or whichever is applicable of
the TDI or FLI benefits, and may select the order in which they are taken, but
may not receive more than one kind of paid leave benefits during any period of
time. </p>

</div>

</body>

</html>
